{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:52:02Z","timestamp":1765885922874},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-230x-13-145","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T15:05:05Z","timestamp":1380639905000},"source":"Crossref","is-referenced-by-count":6,"title":["Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial"],"prefix":"10.1186","volume":"13","author":[{"given":"Hubert","family":"M\u00f6nnikes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christo","family":"van Rensburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Straszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Theek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhold","family":"L\u00fchmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Tholen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"issue":"8","key":"1009_CR1","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006, 101 (8): 1900-1920. 10.1111\/j.1572-0241.2006.00630.x.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1009_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2036.2012.05106.x","volume":"36","author":"G Brunner","year":"2012","unstructured":"Brunner G, Athmann C, Schneider A: Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15\u00a0years in severe acid-peptic disease. Aliment Pharmacol Ther. 2012, 36 (1): 37-47. 10.1111\/j.1365-2036.2012.05106.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1009_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2036.2008.03596.x","volume":"27","author":"B Nojkov","year":"2008","unstructured":"Nojkov B, Rubenstein JH, Adlis SA, Shaw MJ, Saad R, Rai J, Weinman B, Chey W: The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008, 27 (6): 473-482. 10.1111\/j.1365-2036.2008.03596.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1009_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2036.2008.03922.x","volume":"29","author":"G Holtmann","year":"2009","unstructured":"Holtmann G, Chassany O, Devault KR, Schmitt H, Gebauer U, Doerfler H, Malagelada JR: International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2009, 29 (6): 615-625. 10.1111\/j.1365-2036.2008.03922.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"1009_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1155\/2012\/235476","volume":"26","author":"SJ van Zanten","year":"2012","unstructured":"van Zanten SJ, Henderson C, Hughes N: Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review. Can J Gastroenterol. 2012, 26 (4): 196-204.","journal-title":"Can J Gastroenterol"},{"issue":"Suppl 2","key":"1009_CR6","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1097\/MCG.0b013e31821fbf44","volume":"45","author":"H M\u00f6nnikes","year":"2011","unstructured":"M\u00f6nnikes H: Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol. 2011, 45 (Suppl 2): S98-S101.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"1009_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/gutjnl-2011-300798","volume":"61","author":"F Zerbib","year":"2012","unstructured":"Zerbib F, Belhocine K, Simon M, Capdepont M, Mion F, Bruley des Varannes S, Galmiche JP: Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitos in gastro-oesophageal reflux disease. Gut. 2012, 61 (4): 501-506. 10.1136\/gutjnl-2011-300798.","journal-title":"Gut"},{"issue":"3","key":"1009_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0016-5085(95)90373-9","volume":"109","author":"L Agr\u00e9us","year":"1995","unstructured":"Agr\u00e9us L, Sv\u00e4rdsudd K, Nyr\u00e9n O, Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995, 109 (3): 671-680. 10.1016\/0016-5085(95)90373-9.","journal-title":"Gastroenterology"},{"issue":"11","key":"1009_CR9","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1111\/j.1572-0241.2003.07699.x","volume":"98","author":"NJ Talley","year":"2003","unstructured":"Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003, 98 (11): 2454-2459. 10.1111\/j.1572-0241.2003.07699.x.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1009_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000121356","volume":"26","author":"E Bolling-Sternevald","year":"2008","unstructured":"Bolling-Sternevald E, Aro P, Ronkainen J: Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study. Dig Dis. 2008, 26 (3): 256-263. 10.1159\/000121356.","journal-title":"Dig Dis"},{"issue":"9","key":"1009_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/gut.2008.175810","volume":"58","author":"E Savarino","year":"2009","unstructured":"Savarino E, Pohl D, Zentilin P, Dulbecco P, Sammito G, Sconfienza L, Vigneri S, Camerini G, Tutuian R, Savarino V: Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009, 58 (9): 1185-1191. 10.1136\/gut.2008.175810.","journal-title":"Gut"},{"issue":"8","key":"1009_CR12","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1365-2036.2008.03813.x","volume":"28","author":"AC Ford","year":"2008","unstructured":"Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P: Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther. 2008, 28 (8): 1013-1020. 10.1111\/j.1365-2036.2008.03813.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1009_CR13","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1053\/j.gastro.2010.01.043","volume":"138","author":"AC Ford","year":"2010","unstructured":"Ford AC, Thabane M, Collins SM, Moayyedi P, Garg AX, Clark WF, Marshall JK: Prevalence of uninvestigated dyspepsia 8\u00a0years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology. 2010, 138 (5): 1727-1736. 10.1053\/j.gastro.2010.01.043.","journal-title":"Gastroenterology"},{"issue":"4","key":"1009_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00535-011-0379-9","volume":"46","author":"AC Ford","year":"2011","unstructured":"Ford AC, Talley NJ: Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol. 2011, 46 (4): 421-431. 10.1007\/s00535-011-0379-9.","journal-title":"J Gastroenterol"},{"issue":"11","key":"1009_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/MED.0b013e32831e9c8e","volume":"16","author":"M Camilleri","year":"2009","unstructured":"Camilleri M: Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2009, 16 (11): 53-59.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"Suppl 1","key":"1009_CR16","doi-asserted-by":"publisher","first-page":"i67","DOI":"10.1136\/gut.51.suppl_1.i67","volume":"51","author":"M Delvaux","year":"2002","unstructured":"Delvaux M: Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut. 2002, 51 (Suppl 1): i67-i71.","journal-title":"Gut"},{"issue":"3 Suppl","key":"1009_CR17","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0002-9270(03)00010-8","volume":"98","author":"JJ Ofman","year":"2003","unstructured":"Ofman JJ: The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003, 98 (3 Suppl): S8-S14.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"1009_CR18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1365-2036.2012.05085.x","volume":"35","author":"H M\u00f6nnikes","year":"2012","unstructured":"M\u00f6nnikes H, Schwan T, van Rensburg C, Straszak A, Theek C, Sander P, L\u00fchmann R: Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2012, 35 (11): 1279-1289. 10.1111\/j.1365-2036.2012.05085.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"1009_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000101020","volume":"75","author":"KD Bardhan","year":"2007","unstructured":"Bardhan KD, Bergh\u00f6fer P: Look\u2014but also listen! ReQuest\u2122: an essay on a new validated scale to assess the outcome of GERD treatment. Digestion. 2007, 75 (Suppl 1): 87-100.","journal-title":"Digestion"},{"key":"1009_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-230X-11-52","volume":"11","author":"RC Heading","year":"2011","unstructured":"Heading RC, M\u00f6nnikes H, Tholen A, Schmitt H: Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole. BMC Gastroenterol. 2011, 11: 52-10.1186\/1471-230X-11-52.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"1009_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/00365520510011579","volume":"40","author":"J Ronkainen","year":"2005","unstructured":"Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agr\u00e9us L: High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005, 40 (3): 275-285. 10.1080\/00365520510011579.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"1009_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","volume":"134","author":"RB Sartor","year":"2008","unstructured":"Sartor RB: Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008, 134 (2): 577-594. 10.1053\/j.gastro.2007.11.059.","journal-title":"Gastroenterology"},{"issue":"5","key":"1009_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/MCO.0b013e328348c033","volume":"14","author":"EM Quigley","year":"2011","unstructured":"Quigley EM: Commensal bacteria: the link between IBS and IBD?. Curr Opin Clin Nutr Metab Care. 2011, 14 (5): 497-503. 10.1097\/MCO.0b013e328348c033.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"1009_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2036.2008.03699.x","volume":"28","author":"PJ De Jonge","year":"2008","unstructured":"De Jonge PJ, Siersema PD, Van Breda SG, Van Zoest KP, Bac DJ, Leeuwenburgh I, Ouwendijk RJ, Van Dekken H, Kusters JG, Kuipers EJ: Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts. Aliment Pharmacol Ther. 2008, 28 (1): 127-136. 10.1111\/j.1365-2036.2008.03699.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1009_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3164\/jcbn.2007012","volume":"41","author":"H Isomoto","year":"2007","unstructured":"Isomoto H, Nishi Y, Kanazawa Y, Shikuwa S, Mizuta Y, Inoue K, Kohno S: Immune and inflammatory responses in GERD and lansoprazole. J Clin Biochem Nutr. 2007, 41 (2): 84-91. 10.3164\/jcbn.2007012.","journal-title":"J Clin Biochem Nutr"},{"issue":"3","key":"1009_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ajg.2011.377","volume":"107","author":"BD Naliboff","year":"2012","unstructured":"Naliboff BD, Kim SE, Bolus R, Bernstein CN, Mayer EA, Chang L: Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis. Am J Gastroenterol. 2012, 107 (3): 451-459. 10.1038\/ajg.2011.377.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1009_CR27","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1053\/j.gastro.2005.11.057","volume":"130","author":"RL Levy","year":"2006","unstructured":"Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, Creed F: Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology. 2006, 130 (3): 1447-1458.","journal-title":"Gastroenterology"},{"issue":"9","key":"1009_CR28","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.4065\/82.9.1065","volume":"82","author":"DE McAlpine","year":"2007","unstructured":"McAlpine DE, O\u2019Kane DJ, Black JL, Mrazek DA: Cytochrome P450 2D6 genotype variation and venlafaxine dosage. Mayo Clin Proc. 2007, 82 (9): 1065-1068. 10.4065\/82.9.1065.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"1009_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/archpsyc.65.5.551","volume":"65","author":"M Pollack","year":"2008","unstructured":"Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R: Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008, 65 (5): 551-562. 10.1001\/archpsyc.65.5.551.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"1009_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1742-1241.2010.02615.x","volume":"65","author":"L Citrome","year":"2011","unstructured":"Citrome L: Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder. Int J Clin Pract. 2011, 65 (3): 330-340. 10.1111\/j.1742-1241.2010.02615.x.","journal-title":"Int J Clin Pract"},{"issue":"11","key":"1009_CR31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/gps.1007","volume":"18","author":"JS Kennedy","year":"2003","unstructured":"Kennedy JS, Jeste D, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, Breier A: Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial. Int J Geriatr Psychiatry. 2003, 18 (11): 1013-1020. 10.1002\/gps.1007.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"11","key":"1009_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0149-2918(00)83028-3","volume":"22","author":"CM Beasley Jr","year":"2000","unstructured":"Beasley CM, Koke SC, Nilsson ME, Gonzales JS: Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis. Clin Ther. 2000, 22 (11): 1319-1330. 10.1016\/S0149-2918(00)83028-3.","journal-title":"Clin Ther"},{"issue":"4","key":"1009_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejpain.2004.11.001","volume":"9","author":"AV Apkarian","year":"2005","unstructured":"Apkarian AV, Bushnell MC, Treede RD, Zubieta JK: Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005, 9 (4): 463-484. 10.1016\/j.ejpain.2004.11.001.","journal-title":"Eur J Pain"},{"issue":"2\u20133","key":"1009_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.drugalcdep.2007.03.015","volume":"90","author":"II Galynker","year":"2007","unstructured":"Galynker II, Eisenberg D, Matochik JA, Gertmenian-King E, Cohen L, Kimes AS, Contoreggi C, Kurian V, Ernst M, Rosenthal RN, Prosser J, London ED: Cerebral metabolism and mood in remitted opiate dependence. Drug Alcohol Depend. 2007, 90 (2\u20133): 166-174.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"1009_CR35","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.4088\/JCP.v63n1115","volume":"63","author":"HC Margolese","year":"2002","unstructured":"Margolese HC, Annable L, Dion Y: Depression and dysphoria in adult and adolescent patients with Tourette\u2019s disorder treated with risperidone. J Clin Psychiatry. 2002, 63 (11): 1040-1044. 10.4088\/JCP.v63n1115.","journal-title":"J Clin Psychiatry"},{"key":"1009_CR36","doi-asserted-by":"publisher","first-page":"9340","DOI":"10.1186\/1757-1626-2-9340","volume":"2","author":"SH Hosseini","year":"2009","unstructured":"Hosseini SH, Salehifar E: Social phobia following maprotiline: the first case report. Cases J. 2009, 2: 9340-10.1186\/1757-1626-2-9340.","journal-title":"Cases J"},{"key":"1009_CR37","doi-asserted-by":"publisher","first-page":"d4551","DOI":"10.1136\/bmj.d4551","volume":"343","author":"C Coupland","year":"2011","unstructured":"Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J: Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011, 343: d4551-10.1136\/bmj.d4551.","journal-title":"BMJ"},{"issue":"2","key":"1009_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4088\/JCP.09m05214yel","volume":"72","author":"JO Brooks 3rd","year":"2011","unstructured":"Brooks JO, Goldberg JF, Ketter TA, Miklowitz DJ, Calabrese JR, Bowden CL, Thase ME: Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the systematic treatment enhancement program for bipolar disorder. J Clin Psychiatry. 2011, 72 (2): 240-247. 10.4088\/JCP.09m05214yel.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"1009_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1192\/bjp.bp.108.061960","volume":"195","author":"R Uher","year":"2009","unstructured":"Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W, Kozel D, Hauser J, Souery D, Placentino A, Strohmaier J, Perroud N, Zobel A, Rajewska-Rager A, Dernovsek MZ, Larsen ER, Kalember P, Giovannini C, Barreto M, McGuffin P, Aitchison KJ: Adverse reactions to antidepressants. Br J Psychiatry. 2009, 195 (3): 202-210. 10.1192\/bjp.bp.108.061960.","journal-title":"Br J Psychiatry"},{"issue":"10","key":"1009_CR40","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2165\/00002018-200831100-00004","volume":"31","author":"G Gartlehner","year":"2008","unstructured":"Gartlehner G, Thieda P, Hansen RA, Gaynes BN, Deveaugh-Geiss A, Krebs EE, Lohr KN: Comparative risk for harms of second-generation antidepressants: a systematic review and meta-analysis. Drug Saf. 2008, 31 (10): 851-865. 10.2165\/00002018-200831100-00004.","journal-title":"Drug Saf"},{"issue":"5","key":"1009_CR41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ajg.2011.30","volume":"106","author":"M Camilleri","year":"2011","unstructured":"Camilleri M: Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011, 106 (5): 835-842. 10.1038\/ajg.2011.30.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"1009_CR42","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2165\/00023210-200216110-00011","volume":"16","author":"RB Muijsers","year":"2002","unstructured":"Muijsers RB, Plosker GL, Noble S: Spotlight on sertraline in the management of major depressive disorder in elderly patients. CNS Drugs. 2002, 16 (11): 789-794. 10.2165\/00023210-200216110-00011.","journal-title":"CNS Drugs"},{"issue":"2","key":"1009_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/157488608784529251","volume":"3","author":"RJ Flanagan","year":"2008","unstructured":"Flanagan RJ: Side effects of clozapine and some other psychoactive drugs. Curr Drug Saf. 2008, 3 (2): 115-122. 10.2174\/157488608784529251.","journal-title":"Curr Drug Saf"},{"issue":"8","key":"1009_CR44","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/j.1572-0241.1998.440_j.x","volume":"93","author":"A Morris-Yates","year":"1998","unstructured":"Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G: Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998, 93 (8): 1311-1317. 10.1111\/j.1572-0241.1998.440_j.x.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1009_CR45","doi-asserted-by":"publisher","first-page":"907","DOI":"10.4065\/75.9.907","volume":"75","author":"GR Locke 3rd","year":"2000","unstructured":"Locke GR, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ: Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000, 75 (9): 907-912. 10.4065\/75.9.907.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1009_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ajg.2008.139","volume":"104","author":"DR de Vries","year":"2009","unstructured":"de Vries DR, ter Linde JJ, van Herwaarden MA, Smout AJ, Samsom M: Gastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3). Am J Gastroenterol. 2009, 104 (2): 281-285. 10.1038\/ajg.2008.139.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1009_CR47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ncpgasthep0717","volume":"4","author":"B Adam","year":"2007","unstructured":"Adam B, Liebregts T, Holtmann G: Mechanisms of disease: genetics of functional gastrointestinal disorders\u2013searching the genes that matter. Nat Clin Pract Gastroenterol Hepatol. 2007, 4 (2): 102-110. 10.1038\/ncpgasthep0717.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"4","key":"1009_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000331468","volume":"84","author":"G Holtmann","year":"2011","unstructured":"Holtmann G, van Rensburg C, Schwan T, Sander P, Siffert W: Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein \u03b23 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?. Digestion. 2011, 84 (4): 289-298. 10.1159\/000331468.","journal-title":"Digestion"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-13-145\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T08:49:53Z","timestamp":1548146993000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-13-145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-13-145","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,1]]},"article-number":"145"}}